Trupanion, Inc. (TRUP) Earnings

Management highlights

- Overall Financial and Growth Performance * Delivered a strong quarter, with total adjusted operating income up 24% year-over-year to $43.3 million, exceeding management expectations. * This is the fifth consecutive quarter of positive net income; operating cash flow was $21 million (up from $15 million YoY) and free cash flow was $19.2 million (up from $12 million YoY), with 82.2 million in free cash flow accumulated over the past four quarters. * Net addition of approximately 18,800 subscription pets in the quarter, 39% higher than the prior year period, with trailing 12-month average monthly retention of 98.37%, up from 98.29% YoY. * Ended the quarter with $398.5 million in cash and short-term investments, and total debt of $106.9 million, a $7.6 million year-over-year reduction. Subsequent to quarter end, the company received approval for a $44 million capital dividend from its largest insurance entity, bringing total unlocked excess capital from insurance entities to $130 million over three years, and authorized a $100 million share repurchase program to be deployed opportunistically. - Product and Customer Experience Initiatives * Refined the customer enrollment journey to improve clarity of the value proposition, which drove improved web conversion in the quarter while phone conversion remained near record levels. * Expanded deductible and coinsurance options for the core Trupanion product to increase accessibility by offering more affordable monthly pricing, with 50% of the North American rollout completed as of quarter end, on track for full completion by the end of 2026. Early market reception is positive, unlocking a new consumer segment previously unreachable by the company. * On track to launch a new digital insurance offering in the first half of the current strategic plan (midway through 2027) to reach new customer segments and grow the overall pet insurance market. * The pet food initiative continues development, with manufacturing facility work nearing completion; robust testing will begin after construction, and no meaningful revenue contribution is expected during the current strategic plan, as this is a long-term investment. - Technology and Investment Strategy * Continues to invest in AI and automation to reduce operational friction, improve efficiency, create operating leverage, and free teams to focus on high-value customer interactions, while preserving the brand's expected member and partner experience. * Maintains a disciplined capital allocation approach, prioritizing investments that generate the highest long-term shareholder value, including new pet acquisition, product enhancement, technology and capability development.

Guidance

- Full year 2026 guidance was narrowed: total revenue is expected in the range of $1.584 billion to $1.601 billion, and subscription revenue is expected between $1.124 billion and $1.133 billion, with the midpoint of subscription revenue increasing slightly to represent approximately 14% year-over-year growth. - Full year 2026 total adjusted operating income guidance was narrowed to $176 million to $184 million, representing 19% year-over-year growth at the midpoint, maintaining the prior target of $180 million at the midpoint. - Q3 2026 guidance: total revenue expected between $399 million to $405 million, subscription revenue expected between $284 million to $287 million (13% year-over-year growth at the midpoint), and total adjusted operating income expected between $44 million to $47 million (11% year-over-year growth at the midpoint). - All guidance assumes a 71% U.S.-Canadian dollar conversion rate, and revenue projections remain subject to currency exchange rate movements.

Segment performance

1. Subscription Business Segment: Q2 2026 revenue was $276.7 million, growing year-over-year. The segment delivered adjusted operating income of $41.4 million, a 24% year-over-year increase, and contributed 96% of the company's total adjusted operating income for the quarter. Subscription adjusted operating margin was 15%, up from 13.8% in the prior year period. Cost of veterinary invoices as a percentage of subscription revenue was 70.2%, down from 71.1% year-over-year; variable expenses were 9% of revenue (down from 9.1% YoY); fixed expenses were 5.8% of revenue (down from 6% YoY). As of quarter end, total subscription pets stood at 1,125,000, a 5% year-over-year increase, including 66,000 pets in Europe. 2. Other Business Segment: Q2 2026 revenue was $116.2 million, a 4% year-over-year increase. Adjusted operating income for the segment was $1.9 million, equal to 1.6% of segment revenue.

Risks & headwinds

- Forward-looking statements regarding future operations, growth, product launches, and performance involve a high degree of known and unknown risks and uncertainties that could cause actual results to differ materially from expectations, with detailed risk disclosures available in the company's recent SEC filings (10-K, 10-Q, 8-K) and earnings release. - Industry-wide veterinary inflation remains at double-digit levels, higher than pre-pandemic historical averages, though management expects it to normalize over time and has incorporated these expectations into current pricing. - The company faces an industry-wide downturn in new veterinary visits, though management notes the addressable market of uninsured pets remains vast.

Analyst Q&A

• Q: How is veterinary inflation trending, and how is the company managing it? /

  A: Management notes veterinary inflation remains higher than historical levels at a double-digit rate, though it has moderated from recent peaks. Inflation expectations are fully incorporated into the company's current pricing, which is why the business is seeing higher than average pricing across the book of business. The trend reflects veterinary clinics raising prices to maintain overall revenue as wellness visit volumes decline.

• Q: What is the rationale for the new $100 million share repurchase program, and does the company have confidence it can deploy the full authorization? /

  A: The company unlocked $44 million in excess capital from its insurance subsidiary following this dividend, bringing total unlocked capital to $130 million over three years, which leaves approximately $100 million in available operating cash after existing investment commitments. Management evaluates all capital deployments (including internal growth investments and share repurchases) based on internal rate of return, and is confident it has the balance sheet strength and cash flow capacity to deploy the repurchase authorization opportunistically alongside ongoing business investments.

• Q: What drove the strong gross pet acquisition growth in the quarter, and how is it split between core and partner products? /

  A: Nearly all of the quarter's gross pet growth came from the core flagship Trupanion subscription business, which grew around 10% year-over-year. Growth has been driven by recent website optimization that improved web conversion, as well as early success from the new expanded deductible and coinsurance product options, which are filling a previous affordability gap at enrollment and driving higher new customer volumes. The company has retained financial flexibility to continue testing and investing to maintain this growth momentum into the second half of the year.

• Q: What is the rollout timeline for the new enrollment and product changes, and what is the update on new long-term product initiatives? /

  A: The expanded deductible and coinsurance rollout is 50% complete across North America and is on track to be fully completed by the end of 2026, with positive early market reception as customers gain more flexibility to adjust monthly premiums to their budget. The new digital pet insurance offering is on track to launch by the midpoint of the current strategic plan (mid-2027) to target an underserved customer segment. The company's pet food initiative is nearing completion of manufacturing development, will enter testing after construction, and is expected to contribute no meaningful revenue in the current strategic plan as a long-term investment.